Depemokimab: a new long-acting anti-IL5 treatment for severe asthma and chronic rhinosinusitis with nasal polyps
puremagic
1个月前
87
10
已完结
1. 系统已在2026-02-11 16:58:10对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
DI Bernstein
Current Opinion in Allergy and Clinical Immunology, 2025
journals.lww.com
… Results of a noninferiority study comparing depemokimab, benralizumab and mepolizumab
are pending. In a DBPC trial of chronic rhinosinusitis with nasal polyps (CRSwNP), depemokimab
was also effective in reducing nasal polyp endoscopy scores and nasal obstruction. … In this
article, publicly available clinical data will be reviewed pertaining to depemokimab in treating
patients with severe asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP). …
